Exogenous melatonin reduces somatic cell count of milk in Holstein cows.

High somatic cell counts in milk caused by mastitis significantly influence the quality of milk and result in substantial annual economic loss. This study evaluated the beneficial effects of melatonin (MT) on milk somatic cell count (SCC) in cows. To examine the effects of melatonin on SCC, one hundred twenty cows were divided into four groups based on milk SCC. In each group, half of the cows were treated with melatonin (S.C.). Melatonin treatment significantly reduced milk SCC. To explore the potential mechanism, 20 cows with relatively high SCC were selected to evaluate the biochemical and immunological profiles of their blood after melatonin treatment. Treatment with MT significantly reduced SCC in milk, lowered serum cortisol concentrations and increased the levels of albumin, alanine transaminase and lactate dehydrogenase. Following treatment with MT, the concentration of IgG and IgM rose transiently then decreased significantly, similar to changes observed for white blood cells and lymphocytes. In conclusion, MT treatment improved the quality of milk by reducing SCC. This may be due to melatonin improving immune activity in cows.

Mastitis is the most common disease in dairy cows1. There are two major forms of this disease, including clinical and subclinical mastitises2. Clinical mastitis is easily identified by swelling and redness in the teat and udder or increased temperature in the infected mammary gland3. However, the subclinical form is difficult to detect because there are no apparent symptoms. It is mainly characterized by an increase in the somatic cell count (SCC) of milk and a decrease in milk production4. Animals are considered to have a subclinical mammary gland infection if milk contains SCC > 1 × 105 cells/mL5. although some studies have used a threshold of 2 × 105 cells/mL6. The extremely high prevalence of subclinical mastitis causes great economic loss in the dairy industry. In China, 40–80% of milking cows have subclinical mammary gland infections, and the annual loss is estimated at 135 million Yuan7. Although antibiotic therapy has a direct and rapid effect on pathogenic bacteria, the frequent use of antibiotics leads to drug-resistant bacteria. In addition, drug residue in milk has a negative impact on human health8. Therefore, alternative therapies for bovine mastitis are necessary.

Reactive oxygen species (ROS) are continuously formed because of biochemical reactions and external stimulations during the substantial metabolic and physiological adaptations cows undergo between pregnancy and lactation9. Excessive ROS production causes oxidative stress in organisms, which is a significant underlying factor in the dysfunction of host immune and inflammatory responses. Thus, oxidative stress in dairy cows inevitably leads to increased susceptibility to a variety of health disorders, particularly during the high-temperature period1011121314. Melatonin (MT), a hormone mainly synthesized in the pineal gland, affects a variety of physiological processes. It is a signalling molecule in circadian rhythms, regulates reproduction for photoperiodic breeders, modulates the neuroendocrine system and provides cardiovascular protection15161718. MT is a potent free radical scavenger and antioxidant192021. In addition to its antioxidant function, MT balances immune responses and can be an immunostimulatory or immunosuppressive agent depending on conditions. For example, during acute inflammation, it exhibits anti-inflammatory effects and suppresses exacerbated immune responses22. MT implants in goats improved milk quality and reduced SCC in milk by decreasing oxidative stress in the udder. Reports have linked high nocturnal levels of MT in cows with low milk SCC23.

This study investigated the effect of MT administration (S.C.) on the quality of the milk produced by cows with subclinical mastitis. Analyses included SCC in milk and cellular and humoural immune responsive parameters in blood24.

Results

Effects of melatonin treatment on SCC in milk

Treatment with MT (4.64 mg/cow/day for 4 days) reduced the milk SCC in all treated groups (Fig. 1), including significant differences between the relatively high SCC groups (groups 2–4) compared with their untreated counterparts. This effect lasted for a minimum of 24 days after the termination of melatonin treatment.

Figure 1

Changes in milk SCC following the subcutaneous injection of melatonin into cows over four consecutive days.

(a) Cows with milk SCC below 1 × 105 cells/mL; this group served as healthy controls. (b) Cows with milk SCC ranging from 1 × 105 to 3 × 105 cells/mL. (c) Cows with milk SCC ranging from 3 × 105 to 5 × 105 cells/mL. (d) Cows with milk SCC ranging from 5 × 105 to 1 × 106 cells/mL. Melatonin was given on 3-Sep, 4-Sep, 5-Sep and 6-Sep. Data are expressed as the means ± SEM (n = 15). “*” represents significant differences (p < 0.05).

Effects of melatonin on plasma cortisol levels

The results of MT treatment on cortisol concentrations are listed in Table 1. Plasma cortisol levels of Holstein cows were positively associated with their milk SCC. In cows with subclinical mastitis, cortisol levels were significantly higher (5.93 ± 1.70 to 6.12 ± 1.68 ng/mL) than in healthy cows, (3.42 ± 0.33 ng/mL). After MT treatment, the relatively high cortisol levels in cows with subclinical mastitis were reduced to normal ranges, as observed in the control group.

Table 1

Effects of subcutaneous injection of melatonin on plasma cortisol in Holstein cows (ng/mL).

Group	Days after treatment
	0	1	3
MT (SCC 3 × 1051 × 106 cells/mL)	6.12 ± 1.68Aa	3.43 ± 1.11Bb	3.12 ± 0.56Bb
NON-MT (SCC 3 × 105–1 × 106 cells/mL)	5.93 ± 1.70Aa	5.26 ± 1.13Aa	5.82 ± 1.53Aa
Healthy control (SCC < 1 × 105 cells/mL)	3.42 ± 0.33b	—	—

MT (melatonin-treated cows); NON-MT (non-melatonin-treated cows). Data expressed as the means ± SEM (n = 20). Values with different superscript letters, such asab, represent a significant difference within the same group, (P < 0.05); values with different superscript lettersAB represent a significant difference between different groups (P < 0.05); the same letters represent no significant difference (P > 0.05).

Effects of melatonin on blood biochemical indices

The results of MT treatment on blood biochemical parameters, including IgG, IgM, albumin, alanine aminotransferase (ALT) and serum lactate dehydrogenase (S-LDH) are listed in Table 2. IgG and IgM levels in cows with subclinical mastitis (10.26 ± 1.31 to 10.86 ± 1.82 g/L) were significantly higher than in control groups (2.63 ± 0.21 g/L to 2.74 ± 0.63 g/L) (p < 0.05). In contrast, the blood levels of ALB, ALT and LDH were significantly lower in cows with subclinical mastitis than in healthy cows. There were no significant differences in blood glucose levels among these groups (p > 0.05). There was a transient increase in blood IgG and IgM levels in cows with subclinical mastitis one day after the termination of melatonin treatment followed by a significant decrease three days after termination. Following treatment, IgM concentrations were reduced to levels observed in the healthy group. Blood ALB, ALT and LDH levels in cows with subclinical mastitis were significantly increased after melatonin treatment compared with their untreated counterparts (p < 0.05). There were no significant differences in the blood levels of LDH among groups before or after melatonin injection.

Table 2

Effects of subcutaneous injection of melatonin on blood biochemical index of Holstein cows.

Group	Index	Before injection	1 d after injection	3 d after injection
MT (SCC:3 × 105–1 × 106 cells/mL)	IgG (g/L)	10.26 ± 1.31Aa	12.18 ± 1.26Ba	8.92 ± 0.63Ca
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		10.86 ± 1.82Aa	10.53 ± 1.35Ab	10.29 ± 1.27Ab
Healthy control (SCC < 1 × 105 cells/mL)		5.87 ± 1.01c	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	IgM (g/L)	2.63 ± 0.21Aa	3.39 ± 0.23Ba	2.14 ± 0.20Aa
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		2.74 ± 0.63Aa	2.75 ± 0.44Ab	2.65 ± 0.44Ab
Healthy control (SCC < 1 × 105 cells/mL)		2.12 ± 0.20b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	ALB (g/L)	29.92 ± 1.44Aa	33.58 ± 1.31Ba	33.92 ± 1.44Ba
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		30.08 ± 1.78Aa	31.75 ± 1.60Ab	28.25 ± 1.22Bb
Healthy control (SCC < 1 × 105 cells/mL)		38.5 ± 2.72c	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	ALT (U/L)	25.42 ± 4.03Aa	34.17 ± 4.04Ba	35.50 ± 4.38Ba
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		24.83 ± 3.93Aa	30.00 ± 4.81Bb	31.42 ± 5.95Bb
Healthy control (SCC < 1 × 105 cells/mL)		35.5 ± 6.42b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	LDH (U/L)	801.33 ± 66.48Aa	940.67 ± 103.13Ba	904.67 ± 96.38Ba
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		847.92 ± 85.03Aa	844.83 ± 86.80Ab	842.83 ± 93.57Ab
Healthy control (SCC < 1 × 105 cells/mL)		945.7 ± 87.28b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	GLU (mmol/L)	4.06 ± 0.23Aa	4.32 ± 0.24Aa	4.21 ± 0.19Aa
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		3.96 ± 0.23Aa	4.16 ± 0.31Aa	4.14 ± 0.23Aa
Healthy control (SCC < 1 × 105 cells/mL)		4.16 ± 0.22a	—	—

MT (melatonin-treated cows); NON-MT (non-melatonin-treated cows). Data expressed as the means ± SEM (n = 10). Values with different superscript letters, such as abrepresent a significant difference within the same group, (P < 0.05); Values with different superscript letters ABrepresent a significant difference between different groups (P < 0.05); The same letters represent no significant difference (P > 0.05).

Effects of melatonin on blood cells

The effects of MT treatment on blood cells are listed in Table 3. WBC, LYM and GRN were significantly higher in cows with subclinical mastitis compared with healthy cows (p < 0.05). There were no significant differences in RBC between groups (p > 0.05). In cows with subclinical mastitis treated with melatonin, the number of WBC and LYM changed in a pattern similar to that described for IgG and IgM, there was a transient increase then a decrease compared with untreated counterparts. However, levels were not reduced to the concentrations observed in the healthy group.

Table 3

Effects of subcutaneous injection of melatonin on white and red blood cell counts of Holstein cows.

Group	Index	Before injection	1 d after injection	3 d after injection
MT (SCC:3 × 105–1 × 106 cells/mL)	WBC (*109 cells/L)	13.74 ± 2.63Aa	16.58 ± 3.95Ba	10.93 ± 2.35Ca
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		13.98 ± 6.29Aa	14.96 ± 7.50Aa	16.35 ± 5.44Aa
Healthy control (SCC < 1 × 105 cells/mL)		8.86 ± 1.18b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	LYM (*109 cells/L)	7.93 ± 4.43Aa	13.63 ± 5.92Aa	6.14 ± 1.48Ba
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		8.62 ± 3.68Aa	8.79 ± 2.59Ab	12.98 ± 5.40Ba
Healthy control (SCC < 1 × 105 cells/mL)		4.75 ± 1.49b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	GRN (*109 cells/L)	4.35 ± 0.79Aa	4.33 ± 0.93Aa	3.68 ± 0.83Aa
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		4.29 ± 0.65Aa	4.64 ± 0.39Ab	4.28 ± 0.94Aa
Healthy control (SCC < 1 × 105 cells/mL)		3.04 ± 0.51b	—	—
MT (SCC:3 × 105–1 × 106 cells/mL)	RBC (*1012 cells/L)	5.69 ± 0.40Aa	5.61 ± 0.37Aa	5.73 ± 0.54Aa
NON-MT (SCC:3 × 105–1 × 106 cells/mL)		6.04 ± 0.47Aa	5.96 ± 0.50Aa	5.86 ± 0.43Aa
Healthy control (SCC < 1 × 105 cells/mL)		5.65 ± 0.54a	—	—

MT (melatonin-treated cows); NON-MT (non-melatonin-treated cows); WBC: white blood cells; LYM: lymphocytes; GRN: granulocyte neutrophil; RBC: red blood cells. Data expressed as the means ± SEM (n = 10). Values with different superscript letters, such as abrepresent a significant difference within the same group, (P < 0.05); values with different superscript letters ABrepresent a significant difference between different groups, (P < 0.05); the same letters represent no significant difference (P > 0.05).

Discussion

SCC in milk is an important index of breast health in cows25. To some degree, the quality of milk is determined by its SCC. A significant increase of SCC in milk indicates a poor quality product, with high SCC accompanied by relatively low levels of butterfat, milk protein, calcium and relatively high levels of sodium and chloride. All these factors lower the nutritional value of milk and, in some cases, necessitate discarding the milk. A high SCC in milk is also an important factor for determining whether to cull a cow. Approximately 30% of cows are culled due to high SCC in their milk26. When SCC in milk is higher than 7 × 105 cells/mL, the culling rate is 3–4 times higher than in cows with milk SCC lower than 2.5 × 105 cells/mL27. In this study, cows with milk SCC greater than 3 × 105 cells/mL were classified as having subclinical mastitis.

ROS, caused by high environmental temperatures, cause immunosuppression in dairy cows, aggravate dairy mastitis and improve SCC28. Dairy cow mastitis is connected with the activity of reactive oxygen species, cortisol, cytokines, and other classic inflammatory mediators29. The conventional treatment for mastitis in cows is antibiotics, due to their rapid therapeutic effect on mastitis. However, the frequent use of antibiotics causes drug resistance, and drug residues in milk directly jeopardize human health, especially in children. Therefore, it is crucial to find suitable alternative therapies for dairy cow mastitis. Naturally occurring antioxidants have antiviral effects, scavenge reactive oxygen species and improve immune response. They also improve reproductive performance in cows, lower SCC in raw milk and reduce the incidence of mastitis30. Dietary supplementation with tea polyphenol effectively reduced the SCC in raw milk31. We observed that melatonin, a naturally occurring antioxidant, effectively eliminates ROS and enhances immunity. We also found that a short period (four days) of administration (S.C.) significantly reduced the SCC of milk in Holstein cows with subclinical mastitis. Cortisol plays a pivotal role in inflammatory responses, such as mastitis. It regulates glucose metabolism, which is a blood immune inhibitor, and inhibits immune-activity. Serum cortisol levels increase in stress states and promote protein decomposition and glycogen dysplasia. When cows are stressed, cortisol secretion increases and immune function is repressed, including the atrophy of immune organs and a decrease in number of lymphocytes and acidophilic leukocytes in blood. All of these factors lead to the inhibition of cellular immunity and resistance to disease32. This is consistent with our observation that blood cortisol levels in cows with subclinical mastitis (milk SCC > 3 × 105 cells/mL) were significantly higher than in healthy cows (milk SCC < 1 × 105 cells/mL). Melatonin injection significantly reduced cortisol levels in cows with subclinical mastitis, possibly via melatonin-mediated suppression of adrenal cell corticotropin releasing hormone and adrenocorticotropic hormone, which leads to a reduction in butyrylcholinesterase cAMP-induced cortisol production. In addition, the rate-limiting step in cortisol synthesis is the conversion of cholesterol to pregnenolone. Melatonin reduces the synthesis of cortisol by inhibiting prostaglandin33. which reduces the concentration of intracellular cAMP in lymphocytes.

IgG and IgM are important factors in immune response and anti-infection. They lyse and activate complements to promote phagocytosis. Research shows that melatonin enhances humoural immunity34. In mice treated with inactivated Venezuelan equine encephalomyelitis virus, subcutaneous injection of melatonin significantly increased serum globulin and IgM levels35. Melatonin administration also enhanced the levels of IgG and IgM in 28-month-old Wistar rats36. We observed that melatonin treatment transiently increased IgG and IgM levels in cows with subclinical mastitis before levels were reduced toward normal. This implies that melatonin treatment decreases symptoms of mastitis while it decreases IgG and IgM levels, consistent with our observation that melatonin treatment decreases SCC in milk. Lymphocytes and neutrophils are also important factors in inflammatory and immune responses. Studies show that extending the illumination time at night decreases the percentage of peripheral lymphocytes, which also suppresses the secretion of melatonin in animals. However, treatment with melatonin significantly increased the percentage of lymphocytes3738. In pinealectomized animals, thymus and spleen function were suppressed, as indicated by a decrease in the number of lymphocytes and neutrophils. Treatment with melatonin led to a full recovery. These studies are consistent with our observation that melatonin injection significantly enhanced the number of lymphocytes in cows with high milk SCC.

Conclusion

We report, for the first time, that subcutaneous injection of melatonin significantly reduces SCC in the milk of cows with subclinical mastitis. The mechanism of action may be related to the antioxidant, anti-inflammatory and immunoenhancement activities of melatonin. For cows with mastitis, the administration of melatonin reduced cortisol levels and upregulated levels of IgG, IgM, lymphocytes and neutrophils. Melatonin is a naturally occurring antioxidant with low to no toxicity that is inexpensive and widely available. SCC in milk directly reflects the quality of the milk and affects the health of consumers. Treatment with melatonin may provide an effective, safe and quick method to lower SCC in milk and replace the use of the antibiotics, which have many potential adverse effects for cows and human health. To understand the exact mechanisms of melatonin’s beneficial effects on cows with high levels of SCC in their milk, additional studies are necessary.

Materials and Methods

Ethics Statement

This study was carried out in strict accordance with the guidelines for the care and use of animals of China Agricultural University. All animal experimental procedures were approved by the Animal Care Commission of the College of Animal Science and Technology, China Agricultural University. Every effort was made to minimize animal pain, suffering, and distress and to reduce the number of animals used.

Management of animals

Studies were performed in a commercial dairy herd in Beijing China. One hundred forty Holstein dairy cows were included in the experiment. The approximate annual milk production was 9,102 to 11,020 kg per cow for the herd during this study period. Cows were milked three times per day and fed with TR diet (NRC2001). The mean annual culling rate for the study period was 29.5%. Lactating cows were reared in cubicle and feeding areas. In the feeding area, water sprinklers facing the resting place of cows were automatically activated when the temperature reached approximately 25 °C.

Experimental design

Experiment I

One hundred twenty cows were divided into four groups (<10 × 104 cells/mL, 1 × 105 to 3 × 105 cells/mL, 3 × 105 to 5 × 105 cells/mL and 5 × 105 to 1 × 106 cells/mL, respectively) depending on milk SCC levels. Each group was randomly subdivided into melatonin treated and untreated cows. Melatonin treated cows were given subcutaneous injections of MT (4.64 mg) for four consecutive days. Milk was sampled to examine the effects of melatonin on milk SCC.

Experiment II

Twenty cows with milk SCC in the range of 3 × 105 to 1 × 106 cells/mL were selected. Half were treated with MT (4.64 mg) for four consecutive days and the remainder served as untreated controls. This experiment was designed to find associations between melatonin treatment, milk SCC and alterations in the biochemical and immunoresponsive parameters in blood. Thus, both milk and blood were sampled from cows at different time points.

Melatonin injection

Melatonin (Sigma-Aldrich Chemical Co. St. Louis, MO, USA.) was dissolved in ethanol and diluted with normal saline while in a darkroom. Each animal was given 4.64 mg melatonin in a parenteral solution. Cows were injected subcutaneously in the neck with melatonin for four consecutive days at 8:00 am.

Blood sampling

Blood samples were drawn from the coccygeal blood vessel of each cow just before the first melatonin injection at 8:00 am. Thereafter, blood samples were collected at 8:00 am on days one and three after the last melatonin injection. Blood samples were collected in the vacutainers containing heparin or EDTA for analyses of cortisol, the number of red blood cells, lymphocytes, and neutrophils and measurement of physiological and biochemical indices, such as IgG, IgM, albumin and alanine transaminase and lactate dehydrogenase. Samples were immediately placed on ice, and plasma was separated by centrifugation within 1 h of collection. Measurements of serum metabolites and routine blood tests were conducted at the laboratories of BJ. XinChuangYuan BIOTECH CO., LTD (Beijing, China).

Milk sampling

Milk was sampled each day for three days before melatonin treatment and then sampled for 18 days after the last melatonin injection. Milk samples were used for analysis of SCC. All samples were collected after morning milking. The milk samples were heated to 40–42 °C. Samples were well shaken, then analysed using a fluorescence optical system (Fossomatic TM Minor; FossElectric; Hillerød; Denmark).

Statistical analysis

Data, expressed as the mean ± SEM, were analysed with univariate analysis of variance (ANOVA) followed by Duncan’s test using SPSS 19.0 statistical software. The significant difference between treatments was set at P < 0.05.

Additional Information

How to cite this article: Yang, M. et al. Exogenous melatonin reduces somatic cell count of milk in Holstein cows. Sci. Rep. 7, 43280; doi: 10.1038/srep43280 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.